Today, AdvaMed, The Medtech Association®, released the following statement from President and CEO Scott Whitaker on the introduction of the bipartisan Ensuring Patient Access to Critical Breakthrough Products Act. The…
AdvaMedDx®, a division of AdvaMed® representing more than 75 manufacturers of innovative in vitro diagnostic (IVD) tests and technologies in the U.S. and abroad, announced today that Thierry Bernard, CEO…
The European Union Council approved legislative changes to the Medical Device Regulation (EU MDR), finalizing a 3-4 ½ year extension on implementation of the new rules for certifying medical devices.…
AdvaMed®, the largest global trade organization representing medical technology companies, released the medtech industry’s “Medical Innovation Agenda for the 118th Congress.” These policy priorities would advance AdvaMed®’s goal to help…
The Advanced Medical Technology Association® (AdvaMed®), the largest trade association representing medical device manufacturers, including all major radiation therapy manufacturers in the U.S. and abroad. released the following statement from…
In a letter to the White House, the Advanced Medical Technology Association® (AdvaMed®) outlined four key priorities in pending regulations for facilities sterilizing medical devices with ethylene oxide (EtO).
This week, the Advanced Medical Technology Association® (AdvaMed®), the world’s largest trade association representing medical device manufacturers, announced the hiring of Shaye Mandle as the new Executive Director of the Center…
AdvaMed® issued a statement from President and CEO Scott Whitaker on the Joint Statement issued by the United States Trade Representative and India’s Ministry of Commerce & Industry at the…
The year-end spending package making its way through Congress includes key provisions championed by the Advanced Medical Technology Association® (AdvaMed®) that will benefit the patients served by the medical technology…
The Advanced Medical Technology Association® (AdvaMed®) asked the U.S. Supreme Court to review and reverse a California appeals court’s decision imposing over $300 million in penalties on a medical device…